CK Life Sciences International (Holdings), Inc. (LSI) Stock Statistics & Valuation Metrics

CK Life Sciences International (Holdings), Inc. has a market cap or net worth of EUR 535.66M. The enterprise value is EUR 11.92B.

Market Cap

EUR 535.66M

Enterprise Value

EUR 11.92B

CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

9,611,072,000

Owned by Insiders

―

Owned by Institutions

0.22%

CK Life Sciences International (Holdings), Inc.’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -1.25%.

Return on Equity (ROE)

-0.05

Return on Assets (ROA)

-0.02

Return on Invested Capital (ROIC)

-1.25%

Return on Capital Employed (ROCE)

-0.02

Revenue Per Employee

2.82M

Profits Per Employee

-98.15K

Employee Count

1,920

Asset Turnover

0.46

Inventory Turnover

3.76

The current PE Ratio of CK Life Sciences International (Holdings), Inc. is -73.13. CK Life Sciences International (Holdings), Inc.’s PEG ratio is -0.61.

PE Ratio

-73.13

PS Ratio

0.85

PB Ratio

1.19

Price to FCF

-14.64

Price to Operating Cash Flow

-61.39

PEG Ratio

-0.61

In the last 12 months, CK Life Sciences International (Holdings), Inc. had revenue of 5.41B and earned -188.45M in profits. Earnings per share was -0.02.

Revenue

5.41B

Gross Profit

785.38M

Operating Income

-135.28M

Pretax Income

-18.01M

Net Income

-188.45M

EBITDA

-49.42M

Earnings Per Share (EPS)

-0.02

In the last 12 months, operating cash flow was -76.72M and capital expenditures -244.98M, giving a free cash flow of -321.70M billion.

Operating Cash Flow

-76.72M

Free Cash Flow

-321.70M

Free Cash Flow per Share

-0.03

CK Life Sciences International (Holdings), Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-6.83%

Earnings Yield

-1.41%

Beta

1.14

52-Week Price Change

-43.75%

50-Day Moving Average

0.06

200-Day Moving Average

0.07

Relative Strength Index (RSI)

28.62

Average Volume (3m)

―

CK Life Sciences International (Holdings), Inc. upcoming earnings date is Mar 16, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 11, 2026

Next Earnings Date

Mar 16, 2027

Ex-Dividend Date

―

CK Life Sciences International (Holdings), Inc. as a current ratio of 0.87, with Debt / Equity ratio of 175.18%

Current Ratio

0.87

Quick Ratio

0.51

Debt to Market Cap

0.76

Net Debt to EBITDA

-121.79

Interest Coverage Ratio

-0.51

In the past 12 months, CK Life Sciences International (Holdings), Inc. has paid 170.44M in taxes.

Income Tax

170.44M

Effective Tax Rate

-9.46

CK Life Sciences International (Holdings), Inc. EV to EBITDA ratio is 144.29, with an EV/FCF ratio of -34.21.

EV to Sales

1.99

EV to EBITDA

144.29

EV to Free Cash Flow

-34.21

EV to Operating Cash Flow

-143.46

CK Life Sciences International (Holdings), Inc. has EUR 535.65M in cash and marketable securities with EUR 6.83B in debt, giving a net cash position of -EUR 6.30B billion.

Cash & Marketable Securities

EUR 535.65M

Total Debt

EUR 6.83B

Net Cash

-EUR 6.30B

Net Cash Per Share

-EUR 0.66

Tangible Book Value Per Share

EUR 0.07

Gross margin is 13.39%, with operating margin of -0.21%, and net profit margin of -1.20%.

Gross Margin

13.39%

Operating Margin

-0.21%

Pretax Margin

1.78%

Net Profit Margin

-1.20%

EBITDA Margin

1.38%

EBIT Margin

-0.21%

The average price target for CK Life Sciences International (Holdings), Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-6.59%

EPS Growth Forecast

79.41%

Smart Score

3

AI Score

―